SCHEMBL4291063

SCHEMBL4291063

COc1cc(OC2CCN(C(=O)OC(C)(C)C)C2)ccc1-c1cccc(N)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.46
PIK3CA P42336 2/20 0.46
PIK3CB P42338 2/20 0.46
PIK3CG P48736 2/20 0.46
NOS3 P29474 1/20 0.45
NOS1 P29475 1/20 0.45
NOS2 P35228 1/20 0.45
PDE4B Q07343 3/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PDE4A P27815 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
CHEK2 O96017 2/20 0.43
USP30 Q70CQ3 1/20 0.42
ABL1 P00519 1/20 0.42
EGFR P00533 1/20 0.42
SRC P12931 1/20 0.42
ABL2 P42684 1/20 0.42
GPR119 Q8TDV5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15122119 0.97 NOS3 (0.51) PIK3CDPIK3CAPIK3CBPIK3CGNOS3
SCHEMBL6695725 0.93 CACNB4 (0.43) NOS3NOS1NOS2PDE4BMEN1
SCHEMBL421347 0.88 NOS1 (0.48) PIK3CDPIK3CANOS3NOS1NOS2
SCHEMBL220177 0.88 CACNB4 (0.41) NOS3NOS1NOS2PDE4BMEN1
SCHEMBL6587914 0.87 CHEK2 (0.43) PIK3CDNOS3NOS1NOS2MEN1
SCHEMBL6583140 0.85 ALOX5AP (0.46) PIK3CDNOS3NOS1NOS2PDE4B
SCHEMBL221708 0.84 NOS1 (0.45) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL4898636 0.84 CACNB4 (0.39) NOS3NOS1NOS2PDE4BMEN1
SCHEMBL957928 0.83 NOS3 (0.47) PIK3CDNOS3NOS1NOS2CHEK2
2-Aminopyridine SCHEMBL6585312 0.83 NOS1 (0.46) PIK3CDPIK3CANOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009158646-A1 THERAPEUTIC COMPUNDS AND RELATED METHODS OF USE ELIXIR PHARMACEUTICALS, INC. (US) 2009-12-30 WO disclosed